Voyager Therapeutics (VYGR) Earnings Date, Estimates & Call Transcripts $5.28 -0.17 (-3.12%) As of 01/13/2025 04:00 PM Eastern Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Voyager Therapeutics Latest Earnings SummaryActual EPS (Nov. 12) -$0.16 Beat By $0.29 Consensus EPS (Nov. 12) -$0.45 Voyager Therapeutics posted Q3 2024 earnings on November 12, 2024, reporting an EPS of -$0.16, which beat the consensus estimate of -$0.45 by $0.29. Quarterly revenue was reported to be $24.63 million, above the consensus estimate of $12.63 million. With a trailing EPS of $0.71 and a P/E Ratio of 7.44, Voyager Therapeutics' earnings are expected to decrease next year, from ($0.89) to ($1.48) per share. Conference CallConference Call Transcript Get Voyager Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Voyager Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataVYGR Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.VYGR Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Voyager Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$0.69-$0.30-$0.50Q2 20252-$0.70-$0.31-$0.51Q3 20252-$0.56-$0.28-$0.42Q4 20252-$0.56-$0.31-$0.44FY 20258($2.51)($1.20)($1.86) Voyager Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails11/12/2024Q3 2024-$0.45-$0.16+$0.29-$0.16$12.63M$24.63M8/6/2024Q2 2024-$0.38-$0.18+$0.20-$0.18$11.52M$29.58M5/13/2024Q1 2024-$0.44-$0.20+$0.24-$0.20$10.33M$19.52M2/28/2024Q4 2023-$0.59$1.25+$1.84$1.25$4.95M$90.06M11/6/2023Q3 2023-$0.58-$0.59 -$0.01-$0.59$1.75M$4.61M8/3/2023Q2 2023-$0.59-$0.51+$0.08-$0.51$2.00M$4.85M Get the Latest News and Ratings for VYGR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Voyager Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/9/2023Q1 2023$0.15$2.94+$2.79$2.94$99.33M$150.48M3/7/2023Q4 2022-$0.57-$0.61 -$0.04-$0.61$12.71M-$1.55M Voyager Therapeutics Earnings - Frequently Asked Questions When did Voyager Therapeutics announce their last quarterly earnings? Voyager Therapeutics (NASDAQ:VYGR) last announced its quarterly earning data on Tuesday, November 12, 2024. Learn more on VYGR's earnings history. Did Voyager Therapeutics beat their earnings estimates last quarter? In the previous quarter, Voyager Therapeutics (NASDAQ:VYGR) reported ($0.16) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.45) by $0.29. Learn more on analysts' earnings estimate vs. VYGR's actual earnings. How can I listen to Voyager Therapeutics's earnings conference call? The conference call for Voyager Therapeutics's latest earnings report can be listened to online. Listen to Conference Call How can I read Voyager Therapeutics's conference call transcript? The conference call transcript for Voyager Therapeutics's latest earnings report can be read online. Read Transcript How much revenue does Voyager Therapeutics generate each year? Voyager Therapeutics (NASDAQ:VYGR) has a recorded annual revenue of $163.78 million. How much profit does Voyager Therapeutics generate each year? Voyager Therapeutics (NASDAQ:VYGR) has a recorded net income of $132.33 million. VYGR has generated $0.71 earnings per share over the last four quarters. What is Voyager Therapeutics's price-to-earnings ratio? Voyager Therapeutics (NASDAQ:VYGR) has a trailing price-to-earnings ratio of 7.44. What is Voyager Therapeutics's EPS forecast for next year? Voyager Therapeutics's earnings are expected to decrease from ($0.89) per share to ($1.48) per share in the next year. More Earnings Resources from MarketBeat Related Companies ANIP Earnings Results SPRY Earnings Results AUPH Earnings Results SNDX Earnings Results SYRE Earnings Results ELVN Earnings Results COLL Earnings Results BCYC Earnings Results NTLA Earnings Results RCKT Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Why Amazon’s Next Earnings Could Trigger a Stock BreakoutS&P 500 Earnings Set to Shine: January's Critical Market TestCiena Rebounds: AI and Strong Guidance Drive Post-Earnings SurgeHistory Hints at a Rebound for Toll Brothers After EarningsAlibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead? This page (NASDAQ:VYGR) was last updated on 1/14/2025 by MarketBeat.com Staff From Our PartnersGreatest crypto bull market in history?A crypto storm is coming Right now, conditions are in place for a historic move we expect will be the great...Stansberry Research | Sponsored$24 trillion tech spotted at Mar-a-Lago?President Trump’s Secret Service was recently spotted using an odd new technology at his home in Mar-a-Lago…Centurion Publishing | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredTrump’s 2nd Term Shocker: New AI ComingForget Nvidia. Legendary investor Louis Navellier is recommending this little-known company because it's he...10 Minute Trades | Sponsored Elon Spotted at Weird Facility in Memphis? What Elon Musk is planning at a remote facility in Memphis may be his greatest achievement to date. Because...Paradigm Press | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredI was wrong. Dead wrong. Something is stirring deep in Silicon Valley. My team and I have been watching the tech markets closely. ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Voyager Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Voyager Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.